Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds
- PMID: 24875092
- PMCID: PMC4781605
- DOI: 10.3310/hta18360
Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds
Abstract
Background: Western industrialised nations face a large increase in the number of older people. People over the age of 60 years account for almost half of the 16.8 million hospital admissions in England from 2009 to 2010. During 2009-10, respiratory infections accounted for approximately 1 in 30 hospital admissions and 1 in 20 of the 51.5 million bed-days.
Objective: To determine the diagnostic accuracy and clinical effectiveness and cost-effectiveness of rapid molecular and near-patient diagnostic tests for influenza, respiratory syncytial virus (RSV) and Streptococcus pneumoniae infections in comparison with traditional laboratory culture.
Methods: We carried out a randomised controlled trial (RCT) to evaluate impact on prescribing and clinical outcomes of point-of-care tests (POCTs) for influenza A and B and pneumococcal infection, reverse transcriptase-polymerase chain reaction (RT-PCR) tests for influenza A and B and RSV A and B, and conventional culture for these pathogens. We evaluated diagnostic accuracy of POCTs for influenza and pneumococcal infection, RT-PCR for influenza and sputum culture for S. pneumoniae using samples collected during the RCT. We did a systematic review and meta-analysis of POCTs for influenza A and B. We evaluated ease and speed of use of each test, process outcomes and cost-effectiveness.
Results: There was no evidence of association between diagnostic group and prescribing or clinical outcomes. Using PCR as 'gold standard', Quidel Influenza A + B POCT detected 24.4% [95% confidence interval (CI) 16.0% to 34.6%] of influenza infections (specificity 99.7%, 95% CI 99.2% to 99.9%); viral culture detected 21.6% (95% CI 13.5% to 31.6%; specificity 99.8%, 95% CI 99.4% to 100%). Using blood culture as 'gold standard', BinaxNOW pneumococcal POCT detected 57.1% (95% CI 18.4% to 90.1%) of pneumococcal infections (specificity 92.5%; 95% CI 90.6% to 94.1%); sputum culture detected 100% (95% CI 2.5% to 100%; specificity 97.2%, 95% CI 94.3% to 98.9%). Overall, pooled estimates of sensitivity and specificity of POCTs for influenza from the literature were 74% (95% CI 67% to 80%) and 99% (95% CI 98% to 99%), respectively. Median intervals from specimen collection to test result were 15 minutes [interquartile range (IQR) 10-23 minutes) for Quidel Influenza A + B POCT, 20 minutes (IQR 15-30 minutes) for BinaxNOW pneumococcal POCT, 50.8 hours (IQR 44.3-92.6 hours) for semi-nested conventional PCR, 29.2 hours (IQR 26-46.9 hours) for real-time PCR, 629.6 hours (IQR 262.5-846.7 hours) for culture of influenza and 84.4 hours (IQR 70.7-137.8 hours) and 71.4 hours (IQR 69.15-84.0 hours) for culture of S. pneumoniae in blood and sputum, respectively. Both POCTs were rated straightforward and undemanding; blood culture was moderately complex and all other tests were complex. Costs and quality-adjusted life-years (QALYs) of each diagnostic strategy were similar. Incrementally, PCR was most cost-effective (78.3% probability at a willingness to pay of £20,000/QALY). Few patients were admitted within a timescale conducive to treatment with a neuraminidase inhibitor according to National Institute for Health and Care Excellence guidance.
Limitations: The accuracy study was limited by inadequate gold standards.
Conclusions: All tests had limitations. We found no evidence that POCTs for influenza or S. pneumoniae, or PCR for influenza or RSV influenced antimicrobial prescribing or clinical outcomes. The total costs and QALYs of each diagnostic strategy were similar, although, incrementally, PCR was the most cost-effective strategy. The analysis does not support routine use of POCTs for either influenza or pneumococcal antigen for adults presenting with acute cardiopulmonary conditions, but suggests that conventional viral culture for clinical diagnosis should be replaced by PCR.
Trial registration: Current Controlled Trials ISRCTN21521552.
Funding: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 18, No. 36. See the NIHR Journals Library website for further project information.
Similar articles
-
Evidence review for rapid tests to inform triage and antibiotic prescribing decisions: Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management: Evidence review B.London: National Institute for Health and Care Excellence (NICE); 2023 Oct. London: National Institute for Health and Care Excellence (NICE); 2023 Oct. PMID: 38170807 Free Books & Documents. Review.
-
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.Health Technol Assess. 2020 Mar;24(15):1-108. doi: 10.3310/hta24150. Health Technol Assess. 2020. PMID: 32202490 Free PMC article. Clinical Trial.
-
Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.Health Technol Assess. 2020 Jun;24(31):1-232. doi: 10.3310/hta24310. Health Technol Assess. 2020. PMID: 32605705 Free PMC article.
-
Performance and ease of use of a molecular point-of-care test for influenza A/B and RSV in patients presenting to primary care.Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1453-1460. doi: 10.1007/s10096-020-03860-5. Epub 2020 Mar 14. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32172369 Free PMC article.
-
A facilitated home-based cardiac rehabilitation intervention for people with heart failure and their caregivers: a research programme including the REACH-HF RCT.Southampton (UK): NIHR Journals Library; 2021 Feb. Southampton (UK): NIHR Journals Library; 2021 Feb. PMID: 33617178 Free Books & Documents. Review.
Cited by
-
Performance of a Novel Point-of-Care Molecular Assay for Detection of Influenza A and B Viruses and Respiratory Syncytial Virus (Enigma MiniLab) in Children with Acute Respiratory Infection.J Clin Microbiol. 2016 Jan;54(1):212-5. doi: 10.1128/JCM.02887-15. Epub 2015 Nov 11. J Clin Microbiol. 2016. PMID: 26560540 Free PMC article.
-
Integration of sample preparation with RNA-Amplification in a hand-held device for airborne virus detection.Anal Chim Acta. 2021 Jun 22;1165:338542. doi: 10.1016/j.aca.2021.338542. Epub 2021 Apr 23. Anal Chim Acta. 2021. PMID: 33975694 Free PMC article.
-
Classification and Regression Tree (CART) analysis to predict influenza in primary care patients.BMC Infect Dis. 2016 Sep 22;16(1):503. doi: 10.1186/s12879-016-1839-x. BMC Infect Dis. 2016. PMID: 27659721 Free PMC article.
-
Missing data in trial-based cost-effectiveness analysis: An incomplete journey.Health Econ. 2018 Jun;27(6):1024-1040. doi: 10.1002/hec.3654. Epub 2018 Mar 24. Health Econ. 2018. PMID: 29573044 Free PMC article.
-
Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward.Diagn Microbiol Infect Dis. 2018 Aug;91(4):331-335. doi: 10.1016/j.diagmicrobio.2018.03.013. Epub 2018 Apr 4. Diagn Microbiol Infect Dis. 2018. PMID: 29706478 Free PMC article.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical